白皮书:连接人类与动物监测数据、抗生素政策与医院抗菌药物管理的实践指南
该白皮书由JPIAMR ARCH和COMBACTE-MAGNET EPI-Net网络联合制定,通过范围综述和RAND改良德尔菲法(18国40余专家)形成34项目标行动清单,以连接监测数据与医院抗菌药物管理(AMS),工具兼顾病例组合、流行病学及低资源可行性。
要点
- 监测数据与AMS活动需通过目标行动清单连接。
- 清单含34项行动,分必需与理想,经两轮共识形成。
- 工具灵活实用,考虑病例组合、流行病学及资源可行性。
核心结论
- 白皮书提供实用灵活工具,指导基于医院监测的AMS干预开发。
- 工具综合考量医院患者病例组合、相关流行病学及低资源可行性。
研究设计与样本
- 范围综述检索三个领域文献:AMS领导与问责、抗菌药物使用与AMS、AMR与AMS。
- 通过RAND改良德尔菲法(18国40余专家)达成目标行动共识。
主要发现
- 从51篇文献中提取证据,初始提出38个目标。
- 第一轮咨询32个目标初步共识,第二轮后批准27个、删除11个、4个建议改写。
- 最终批准34项目标行动,以实用清单形式呈现。
关键数值与推荐
- 目标行动根据临床相关性、可行性和适用性分为必需或理想。
- 最终清单含34项行动,经两轮德尔菲共识形成。
临床怎么用
- 用于指导医院监测数据与AMS活动的连接。
- 可根据医院病例组合、流行病学和资源调整干预措施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Antimicrobial surveillance and antimicrobial stewardship (AMS) are essential pillars in the fight against antimicrobial resistance (AMR), but practical guidance on how surveillance data should be linked to AMS activities is lacking. This issue is particularly complex in the hospital setting due to structural heterogeneity of hospital facilities and services. The JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks have joined efforts to formulate a set of target actions for linking surveillance data with AMS activities. METHODS: A scoping review of the literature was carried out addressing research questions on three areas: (i) AMS leadership and accountability; (ii) antimicrobial usage and AMS; (iii) AMR and AMS. Consensus on the target actions was reached through a RAND-modified Delphi process involving over 40 experts in different fields from 18 countries. RESULTS: Evidence was retrieved from 51 documents. Initially 38 targets were proposed, differentiated as essential or desirable according to clinical relevance, feasibility and applicability to settings and resources. In the first consultation round, preliminary agreement was reached for 32 targets. Following a second consultation, 27 targets were approved, 11 were deleted and 4 were suggested for rephrasing, leading to a final approved list of 34 target actions in the form of a practical checklist. CONCLUSIONS: This White Paper provides a pragmatic and flexible tool to guide the development of calibrated hospital-surveillance-based AMS interventions. The strength of this tool is that it is a comprehensive perspective that takes into account the hospital patient case-mix and the related epidemiology, which ultimately drives antimicrobial usage, and the feasibility in low-resource settings.
引用
- Pezzani MD, Carrara E, Sibani M, et al. White Paper: Bridging the gap between human and animal surveillance data, antibiotic policy and stewardship in the hospital sector-practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks. J Antimicrob Chemother. 2020. PMID: 33280046. doi:10.1093/jac/dkaa426
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。